Cytokinetics (CYTK) – Hot Corp. News
-
Cytokinetics (CYTK) Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
-
Cytokinetics (CYTK) Announces COURAGE-ALS Met Criteria for Futility at Second Interim Analysis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CYTK Stock Lookup